Willis Towers Watson Public (WTW) News Today

Willis Towers Watson Public Limited Company (NASDAQ: WTW) has been trading higher and remains close to its 52-week high, supported by bullish analyst revisions and expectations that rising health-care costs will increase demand for its consulting and cost-management services.

• Positive Sentiment: TD Cowen raised its price target to $455 from $391 and reiterated a “Buy” rating. The new target implies substantial upside from recent trading levels and provides a positive valuation signal for WTW. TD Cowen raises Willis Towers Watson price target
• Positive Sentiment: Zacks Research increased several earnings forecasts for WTW. FY2026 EPS was raised to $19.73 from $19.51, while FY2027 EPS increased to $22.32 from $21.71. Estimates for Q1 2027, Q3 2027 and Q4 2027 were also raised, suggesting improved expectations for longer-term earnings growth. The current full-year consensus estimate is $19.77 per share. Zacks Research earnings estimate revisions for Willis Towers Watson
• Positive Sentiment: Persistent health-care cost inflation could support demand for WTW’s services. Aon expects U.S. employer health-care costs to rise 9.5% in 2027, increasing pressure on employers’ benefits budgets and potentially driving demand for benefits consulting, cost containment and risk-management solutions. Aon health-cost inflation outlook
• Neutral Sentiment: The earnings revisions were mixed. Zacks lowered its Q3 2026 EPS forecast to $3.51 from $3.56, although this was more than offset by increases to later-quarter and full-year estimates.